Chris A. Rallis, Director at FENNEC PHARMACEUTICALS INC. (FENC), sold 333 shares at $7.99 ($3K) on 2022-11-17, disclosed to the SEC on 2022-11-17.
Scheduled sale ($3k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| FENC | SELL | 2025-07-07 | $10K | — | Filing → |
| FENC | SELL | 2025-04-11 | $7K | — | Filing → |
| FENC | SELL | 2025-02-14 | $8K | — | Filing → |